Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202699.4%
-
Alnylam Pharmaceuticals Inc. May 16, 202494.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Vaxcyte Inc. | Grant or award | +2,194 | — | — |
| Jun 11, 2026 | BeOne Medicines Ltd. | Grant or award | +18,980 | — | — |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| Jan 15, 2026 | Vaxcyte Inc. | Grant or award | +1,357 | — | — |
| Jun 12, 2025 | Vaxcyte Inc. | Grant or award | +1,148 | — | — |
| May 21, 2025 | BeOne Medicines Ltd. | Grant or award | +10,985 | — | — |
| May 8, 2025 | Alnylam Pharmaceuticals Inc. | Grant or award | +775 | — | — |
| Jun 5, 2024 | BeOne Medicines Ltd. | Grant or award | +16,341 | — | — |
Questions about Olivier Brandicourt
What boards is Olivier Brandicourt on?
Olivier Brandicourt sits on the boards of Alnylam Pharmaceuticals Inc., BeOne Medicines Ltd. and Vaxcyte Inc.
How long has Olivier Brandicourt served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.